Literature DB >> 26962097

Adjunct Screening With Tomosynthesis or Ultrasound in Women With Mammography-Negative Dense Breasts: Interim Report of a Prospective Comparative Trial.

Alberto S Tagliafico1, Massimo Calabrese1, Giovanna Mariscotti1, Manuela Durando1, Simona Tosto1, Francesco Monetti1, Sonia Airaldi1, Bianca Bignotti1, Jacopo Nori1, Antonella Bagni1, Alessio Signori1, Maria Pia Sormani1, Nehmat Houssami2.   

Abstract

PURPOSE: Debate on adjunct screening in women with dense breasts has followed legislation requiring that women be informed about their mammographic density and related adjunct imaging. Ultrasound or tomosynthesis can detect breast cancer (BC) in mammography-negative dense breasts, but these modalities have not been directly compared in prospective trials. We conducted a trial of adjunct screening to compare, within the same participants, incremental BC detection by tomosynthesis and ultrasound in mammography-negative dense breasts. PATIENTS AND METHODS: Adjunct Screening With Tomosynthesis or Ultrasound in Women With Mammography-Negative Dense Breasts is a prospective multicenter study recruiting asymptomatic women with mammography-negative screens and dense breasts. Eligible women had tomosynthesis and physician-performed ultrasound with independent interpretation of adjunct imaging. Outcome measures included cancer detection rate (CDR), number of false-positive (FP) recalls, and incremental CDR for each modality; these were compared using McNemar's test for paired binary data in a preplanned interim analysis.
RESULTS: Among 3,231 mammography-negative screening participants (median age, 51 years; interquartile range, 44 to 78 years) with dense breasts, 24 additional BCs were detected (23 invasive): 13 tomosynthesis-detected BCs (incremental CDR, 4.0 per 1,000 screens; 95% CI, 1.8 to 6.2) versus 23 ultrasound-detected BCs (incremental CDR, 7.1 per 1,000 screens; 95% CI, 4.2 to 10.0), P = .006. Incremental FP recall occurred in 107 participants (3.33%; 95% CI, 2.72% to 3.96%). FP recall (any testing) did not differ between tomosynthesis (FP = 53) and ultrasound (FP = 65), P = .26; FP recall (biopsy) also did not differ between tomosynthesis (FP = 22) and ultrasound (FP = 24), P = .86.
CONCLUSION: The Adjunct Screening With Tomosynthesis or Ultrasound in Women With Mammography-Negative Dense Breasts' interim analysis shows that ultrasound has better incremental BC detection than tomosynthesis in mammography-negative dense breasts at a similar FP-recall rate. However, future application of adjunct screening should consider that tomosynthesis detected more than 50% of the additional BCs in these women and could potentially be the primary screening modality.
© 2016 by American Society of Clinical Oncology.

Entities:  

Year:  2016        PMID: 26962097     DOI: 10.1200/JCO.2015.63.4147

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  51 in total

1.  Preliminary Clinical Experience with a Combined Automated Breast Ultrasound and Digital Breast Tomosynthesis System.

Authors:  Eric D Larson; Won-Mean Lee; Marilyn A Roubidoux; Mitchell M Goodsitt; Chris Lashbrook; Cynthia E Davis; Oliver D Kripfgans; Paul L Carson
Journal:  Ultrasound Med Biol       Date:  2018-01-05       Impact factor: 2.998

2.  Ultrasound positive predictive values by BI-RADS categories 3-5 for solid masses: An independent reader study.

Authors:  A Thomas Stavros; Andrea G Freitas; Giselle G N deMello; Lora Barke; Dennis McDonald; Terese Kaske; Ducly Wolverton; Arnold Honick; Daniela Stanzani; Adriana H Padovan; Ana Paula C Moura; Marilia C V de Campos
Journal:  Eur Radiol       Date:  2017-04-10       Impact factor: 5.315

Review 3.  Applications of Advanced Breast Imaging Modalities.

Authors:  Arwa A Alzaghal; Pamela J DiPiro
Journal:  Curr Oncol Rep       Date:  2018-05-29       Impact factor: 5.075

4.  Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.

Authors:  Janie M Lee; Robert F Arao; Brian L Sprague; Karla Kerlikowske; Constance D Lehman; Robert A Smith; Louise M Henderson; Garth H Rauscher; Diana L Miglioretti
Journal:  JAMA Intern Med       Date:  2019-05-01       Impact factor: 21.873

Review 5.  A review of optical breast imaging: Multi-modality systems for breast cancer diagnosis.

Authors:  Quing Zhu; Steven Poplack
Journal:  Eur J Radiol       Date:  2020-05-18       Impact factor: 3.528

Review 6.  Imaging Surveillance After Primary Breast Cancer Treatment.

Authors:  Diana L Lam; Nehmat Houssami; Janie M Lee
Journal:  AJR Am J Roentgenol       Date:  2017-01-11       Impact factor: 3.959

7.  Digital mammography screening: sensitivity of the programme dependent on breast density.

Authors:  Stefanie Weigel; W Heindel; J Heidrich; H-W Hense; O Heidinger
Journal:  Eur Radiol       Date:  2016-11-07       Impact factor: 5.315

Review 8.  Redefining the sensitivity of screening mammography: A review.

Authors:  Alan B Hollingsworth
Journal:  Am J Surg       Date:  2019-02-02       Impact factor: 2.565

9.  [S3 guideline breast cancer: update on early detection, and mammography screening].

Authors:  Ute-Susann Albert; Ingrid Schreer
Journal:  Radiologe       Date:  2019-01       Impact factor: 0.635

10.  CRISPR Technology for Breast Cancer: Diagnostics, Modeling, and Therapy.

Authors:  Rachel L Mintz; Madeleine A Gao; Kahmun Lo; Yeh-Hsing Lao; Mingqiang Li; Kam W Leong
Journal:  Adv Biosyst       Date:  2018-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.